UroGen Pharma Ltd. logo

UroGen Pharma Ltd.

NASDAQ:URGN

Overview | Financials
Company Name UroGen Pharma Ltd.
Symbol URGN
Currency USD
Price 13.12
Market Cap 552,536,992
Dividend Yield 0%
52-week-range 10.6 - 20.7
Industry Biotechnology
Sector Healthcare
CEO Ms. Elizabeth A. Barrett
Website https://www.urogen.com

An error occurred while fetching data.

About UroGen Pharma Ltd.

UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead product candidate is UGN-102,

Related Stocks

CVRx, Inc. logo

CVRx, Inc.

CVRX

7.85 USD

Annexon, Inc. logo

Annexon, Inc.

ANNX

7.2 USD

Checkpoint Therapeutics, Inc. logo

Checkpoint Therapeutics, Inc.

CKPT

2.3 USD

ChromaDex Corporation logo

ChromaDex Corporation

CDXC

3.55 USD

Werewolf Therapeutics, Inc. logo

Werewolf Therapeutics, Inc.

HOWL

2.34 USD

Jasper Therapeutics, Inc. logo

Jasper Therapeutics, Inc.

JSPR

22.75 USD

Financials

Numbers are in millions USD

Numbers are in millions USD